Xenon Pharmaceuticals
XENE
#3136
Rank
โ‚ฌ4.34 B
Marketcap
44,93ย โ‚ฌ
Share price
-2.38%
Change (1 day)
62.97%
Change (1 year)

EPS for Xenon Pharmaceuticals (XENE)

EPS in 2026 (TTM): -4,01ย โ‚ฌ

According to Xenon Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -4,08ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -3,79ย โ‚ฌ a decrease over its 2024 EPS that were of -2,62ย โ‚ฌ.

EPS history for Xenon Pharmaceuticals from 2022 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-4,01ย โ‚ฌ6%
2025-3,79ย โ‚ฌ44.37%
2024-2,62ย โ‚ฌ11.03%
2023-2,36ย โ‚ฌ33.33%
2022-1,77ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Coherus BioSciences
CHRS
1,16ย โ‚ฌ-128.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Atara Biotherapeutics
ATRA
1,93ย โ‚ฌ-147.23%๐Ÿ‡บ๐Ÿ‡ธ USA